Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Crescent Capital BDC, Inc. (CCAP) Financial Statements

Crescent Capital BDC, Inc. (CCAP) reported trailing twelve-month revenue of $156.4M (down 14.6% year on year) and net income of -$3.2M as of 2026-06-30, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CCAPCrescent Capital BDC, Inc.Follow CCAP — free
Asset Management · Financials
—
Price chart with a free account
Market cap
319.1M
P/E TTM
—
Dividend yield
20.4%
52-week
—
Next earnings
11 Nov, in 18 days

Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.

LineFY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Revenue0.180.200.170.16
Operating income-0.10-0.11-0.10-0.09
Pre-tax income0.080.090.070.06
Income tax0.000.000.000.00
Net income0.080.070.03-0.00
Diluted EPS ($)2.302.401.81-0.09
Diluted shares (bn)0.0360.0370.037—

USD billions · SEC XBRL

Crescent Capital BDC, Inc. — questions

What is Crescent Capital BDC, Inc.'s revenue?
$156.4M over the twelve months to 2026-06-30, down 14.6% year on year, from its 10-Q and 10-K filings.
What is Crescent Capital BDC, Inc.'s net income?
-$3.2M over the twelve months to 2026-06-30.
What are Crescent Capital BDC, Inc.'s diluted earnings per share?
$-0.09 over the twelve months to 2026-06-30.

Every figure on this page comes from Crescent Capital BDC, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.